InvestorsHub Logo
Post# of 253518
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: ThomasS post# 87734

Friday, 12/18/2009 11:35:45 AM

Friday, December 18, 2009 11:35:45 AM

Post# of 253518
CELG/Revlimid CALGB trial in treating patients who are undergoing autologous stem cell transplant for multiple myeloma was stopped early due to superior efficacy:

http://www.reuters.com/article/idCNN1821779320091218?rpc=44
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.